Machine Learning To Stratify Methicillin-Resistant Staphylococcus aureus Risk among Hospitalized Patients with Community-Acquired Pneumonia
Antimicrobial Agents and Chemotherapy · 24.01.2023 · 67 (1)
DOI: 10.1128/aac.01023-22 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 24.01.2023. Verfasst von Nathaniel J Rhodes und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice, Midwestern University, Chicago College of Pharmacy, Downers Grove, Illinois, USA. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Community-Acquired Infections, Pneumonia, Staphylococcal, Staphylococcal Infections. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCATS NIH HHS, Division of Intramural Research, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Methicillin-resistant Staphylococcus aureus (MRSA) is an uncommon but serious cause of community-acquired pneumonia (CAP). A lack of validated MRSA CAP risk factors can result in overuse of empirical broad-spectrum antibiotics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy Practice, Midwestern University, Chicago College of Pharmacy, Downers Grove, Illinois, USA.
- Pharmacometrics Center of Excellence, Midwestern University, Downers Grove, Illinois, USA.
- Department of Pharmacy, Northwestern Memorial Hospital, Chicago, Illinois, USA.
- Optimal Data Analysis, LLC, Chicago, Illinois, USA.
- Clinical Translational Sciences Institute, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
- Department of Microbiology, Northwestern Memorial Hospital, Chicago, Illinois, USA.
ORCID-Profile: Nathaniel J Rhodes, Roxane Rohani, Paul R Yarnold, Richard G Wunderink
Förderung
- NIAID NIH HHS
- NCATS NIH HHS
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases
- HHS | NIH | National Center for Advancing Translational Sciences
- American Association of Colleges of Pharmacy
Zitieren
APA
Rhodes, N. J., Rohani, R., Yarnold, P. R., Pawlowski, A. E., Malczynski, M., Qi, C., Sutton, S. H., Zembower, T. R., & Wunderink, R. G. (2023). Machine Learning To Stratify Methicillin-Resistant Staphylococcus aureus Risk among Hospitalized Patients with Community-Acquired Pneumonia. Antimicrobial Agents and Chemotherapy, 67(1). https://doi.org/10.1128/aac.01023-22
Vancouver
Rhodes NJ, Rohani R, Yarnold PR, Pawlowski AE, Malczynski M, Qi C, et al. Machine Learning To Stratify Methicillin-Resistant Staphylococcus aureus Risk among Hospitalized Patients with Community-Acquired Pneumonia. Antimicrobial Agents and Chemotherapy. 2023;67(1). doi:10.1128/aac.01023-22
BibTeX
@article{Rhodes2023,
author = {Rhodes, Nathaniel J and Rohani, Roxane and Yarnold, Paul R and Pawlowski, Anna E and Malczynski, Michael and Qi, Chao and Sutton, Sarah H and Zembower, Teresa R and Wunderink, Richard G},
title = {Machine Learning To Stratify Methicillin-Resistant Staphylococcus aureus Risk among Hospitalized Patients with Community-Acquired Pneumonia},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2023},
volume = {67},
number = {1},
doi = {10.1128/aac.01023-22}
}
EUVIMED